Switch to
More onapp

How to use scorecard? Learn more

Indo Us Bio-Tech Ltd

INDOUS
nanAgro Products
SmallcapWith a market cap of ₹612 cr, stock is ranked 1,739
High RiskStock is 4.95x as volatile as Nifty
282.856.70 (-2.31%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Bad

Insufficient Data

Red flags

Low

No red flag found

How to use scorecard? Learn more

nanAgro Products
SmallcapWith a market cap of ₹612 cr, stock is ranked 1,739
High RiskStock is 4.95x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
48.11
PB RatioPB Ratio
9.77
Dividend YieldDiv. Yield
Sector PESector PE
Sector PBSector PB
Sector Div YldSctr Div Yld

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Indo US Bio-Tech Limited is a company engaged in research and development, breeding, production, processing, packing, and marketing of hybrid and open pollinated varieties of agricultural crops. They also educate local farmers through demonstrations of various cultivated research crops. Their product portfolio includes a variety of agriculture seeds for vegetables, oilseeds, pulses, cereals, and spices. They have a distribution network in multiple states in India and export to countries like the United States, Palestine, Cameroon, Kuwait, Sri Lanka, and Mauritius.

Financial TrendFinancial statements 

202120222023202440.1350.2361.7673.165.105.237.228.25
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Shareholders meeting 
Announced OnOct 1, 2024

Indo Us Biotech Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2024 | Download

Indo Us Biotech Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2024 | Download

Shareholders meeting 
Announced OnSep 30, 2024

Indo Us Biotech Limited has informed the Exchange with copy of minutes of Annual General Meeting held on September 30, 2024 | Download

Indo Us Biotech Limited has informed the Exchange with copy of minutes of Annual General Meeting held on September 30, 2024 | Download

Cash Dividend 
Ex. DateOct 28, 2021

Interim • Div/Share: ₹ 0.25

See all events